Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estrogen receptor scintigraphy

K Scheidhauer1, A Scharl, H Schicha

  • 1Department of Nuclear Medicine, University of Cologne, Germany.

The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)
|July 1, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers.

Journal of cancer research and clinical oncology·2022
Same author

[Somatostatin receptor PET/CT (SSTR-PET/CT)].

Nuklearmedizin. Nuclear medicine·2018
Same author

Abstracts of the 33rd International Austrian Winter Symposium : Zell am See, Austria. 24-27 January 2018.

EJNMMI research·2018
Same author

Survival benefit of pelvic and paraaortic lymphadenectomy in high-grade endometrial carcinoma: a retrospective population-based cohort analysis.

Journal of cancer research and clinical oncology·2017
Same author

[PET-CT and PET-MRI of the prostate : From <sup>18</sup>F-FDG to <sup>68</sup>Ga-PSMA].

Der Radiologe·2017
Same author

[Bone-specific therapy with radium-223 dichloride : Castration-resistant prostate cancer with symptomatic bone metastases].

Der Urologe. Ausg. A·2017
Same journal

The role of labeled Annexin A5 in imaging of programmed cell death. From animal to clinical imaging.

The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR)·2004
Same journal

Imaging cell death in vivo.

The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR)·2004
Same journal

Radiolabelled peptides and low molecular weight proteins in metabolic diseases.

The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR)·2004
Same journal

"Pathophysiologic mapping" of venous thromboembolism: opportunities for radiolabeled peptides.

The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR)·2004
Same journal

Non-oncologic applications of radiolabeled peptides in nuclear medicine.

The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR)·2004
Same journal

The role of octreotide scintigraphy in rheumatoid arthritis and sarcoidosis.

The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR)·2004
See all related articles

Radio-labeled estrogen receptor ligands show promise for in vivo imaging. While 18F tracers face logistical challenges, 123I-labeled estradiol derivatives offer broader potential for estrogen receptor scintigraphy in humans.

Area of Science:

  • Nuclear medicine
  • Radiopharmaceutical chemistry
  • Oncology imaging

Background:

  • Radio-labeled estrogen receptor ligands are used for functional receptor diagnosis.
  • Estrogen receptor scintigraphy is limited for tumor screening and staging due to variable receptor positivity in mammary carcinomas.
  • In vivo imaging of estrogen receptors is achievable with both 18F-labeled and 123I-labeled estradiol derivatives.

Purpose of the Study:

  • To evaluate the suitability of radio-labeled estrogen receptor ligands for in vivo imaging.
  • To compare the applicability of different radiolabeled estradiol derivatives for estrogen receptor scintigraphy.
  • To identify potential optimizations for estrogen receptor scintigraphy.

Main Methods:

  • In vivo imaging of estrogen receptors using 18F-labeled and 123I-labeled estradiol derivatives.

Related Experiment Videos

  • Assessment of tracer specificity and performance in human subjects.
  • Evaluation of logistical requirements and technological factors influencing tracer application.

    • Main Results:

    • High specificity of 18F- and 123I-labeled estradiol derivatives for estrogen receptors confirmed in vivo.
    • 18F-labeled tracers are limited for broad application due to short half-life and proximity requirements to cyclotrons.
    • 123I-labeled estradiol derivatives show widespread application potential due to compatibility with widely available gamma cameras.

    Conclusions:

    • 123I-labeled estradiol derivatives are more suitable for widespread clinical application in estrogen receptor scintigraphy compared to 18F-labeled tracers.
    • Further optimization of tracers for higher tumor contrast and improved excretion profiles is needed.
    • Modern multi-head gamma camera systems can enhance the diagnostic yield of estrogen receptor scintigraphy.